Clinical Trial Update: Phase 3 Study of Tavocept Versus Placebo in Patients With Newly Diagnosed or Relapsed Advanced Primary Adenocarcinoma of the Lung Treated With Docetaxel or Paclitaxel Plus Cisplatin [Phase 3]

View source ↗

Summary

Phase 3 trial update comparing Tavocept to placebo in combination therapy for newly diagnosed or relapsed advanced non-small cell lung cancer treated with docet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Tavocept

Snippet

Sponsor: BioNumerik Pharmaceuticals, Inc. | Conditions: Non-small Cell Lung Cancer | Phase 3 | Status: COMPLETED